With regard to clinical stages, while STAT5a, STAT5b, and STAT6 were related to a positive OS both in stages I/II and III/IV ovarian cancer patients, STAT1 and STAT4 were correlated to a favorable OS in stages III and IV ovarian cancer patients (Table 2). Here, STAT5A is linked to ovarian carcinoma.